Safety Study of Inhaled Saline in Acute Lung Injury



Status:Completed
Conditions:Cardiology, Hospital, Pulmonary
Therapuetic Areas:Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases, Other
Healthy:No
Age Range:18 - Any
Updated:8/15/2015
Start Date:October 2013
End Date:December 2015
Contact:Richard A Oeckler, M.D., Ph.D.
Email:oeckler.richard@mayo.edu
Phone:507-284-2158

Use our guide to learn which trials are right for you!

Inhaled Hypertonic Saline for the Treatment of Acute Lung Injury

To determine if an inhaled hypertonic saline solution has any effect on lung function in
patients with acute respiratory distress syndrome (ARDS).

Hypertonic Saline (HS) aerosols have proven efficacious mucolytics in patient with cystic
fibrosis and are well tolerated in that population. Safety concerns in mechanically
ventilated patients with ARDS center primarily on HS's effects on lung water distribution
(intra vs. extra alveolar) and on airway reactivity. For that reason we plan a small
feasibility trial with narrowly focused physiologic endpoints, namely to measure the effects
of a single 5ml dose of 7% Saline aerosol on blood gas tensions, hemodynamics and the static
and dynamic properties of the relaxed respiratory system. This narrowly scoped study is to
lay the foundation for a larger multicenter intervention trial.

Inclusion Criteria:

- Study participants will include consenting adult patients (age > 18), who had been
intubated and mechanically ventilated for <72 hours and meet international consensus
criteria for ARDS.
We found this trial at
1
site
200 First Street SW
Rochester, Minnesota 55905
507-284-2511
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
?
mi
from
Rochester, MN
Click here to add this to my saved trials